- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | NewGenIvf (NIVF) Stock Soars Over 28% After-Hours: What's Driving the Surge? | 3 | Benzinga.com | ||
| NEWGENIVF GROUP Aktie jetzt für 0€ handeln | |||||
| Mi | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Mi | NewGenIvf schließt öffentliches Angebot über 1,25 Mio. US-Dollar ab | 1 | Investing.com Deutsch | ||
| Mi | NewGenIvf closes $1.25M public offering at $0.07/share | 1 | Investing.com | ||
| Mi | NewGenIVF Group Limited: NewGen Announces Closing of $1.25 Million Public Offering | 2 | GlobeNewswire (USA) | ||
| Di | NewGenIvf announces pricing of $1.25M public offering of shares and pre-funded warrants | 2 | Seeking Alpha | ||
| Di | NewGenIvf prices $1.25M public offering at $0.07 per share | 1 | Investing.com | ||
| Di | NewGenIVF Group Limited: NewGen Announces Pricing of $1.25 Million Public Offering | 1 | GlobeNewswire (USA) | ||
| 10.09. | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 20.08. | NewGenIvf Group Ltd - F-1, Registration statement for certain foreign private issuers | 3 | SEC Filings | ||
| 17.08. | NewGenIVF Group Limited: NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor | 1 | GlobeNewswire (USA) | ||
| 17.08. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 27.07. | NewGenIVF Group Limited: NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million | 422 | GlobeNewswire (Europe) | BANGKOK, July 27, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has entered... ► Artikel lesen | |
| 27.07. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 23.07. | NewGenIVF Group Limited: NewGen's Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai's Valuation Reaches US$200 Million | 1 | GlobeNewswire (USA) | ||
| 06.07. | NewGenIVF Group Limited: NewGen's Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million | 2 | GlobeNewswire (USA) | ||
| 01.07. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 22.06. | NewGenIVF Group Limited: NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization | 292 | GlobeNewswire (Europe) | BANGKOK, June 22, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) ("NewGen" or the "Company") today announced that NewGen's total outstanding shares now stand at 10,073,535 following... ► Artikel lesen | |
| 18.06. | NewGenIVF Group Limited: NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested | 551 | GlobeNewswire (Europe) | K25.ai to complete its US$10 million Pre-A at a US$100 million valuation and is now raising its Series A to accelerate product launch and regional expansion NewGen's expanded stake and exclusive Asia-Pacific... ► Artikel lesen | |
| 18.06. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings |
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 4,889 | -0,20 % | Teladoc Aktie setzt Talfahrt fort: Chefjurist geht, Sorgen bleiben | ||
| SERNOVA BIOTHERAPEUTICS | 0,070 | +3,87 % | Sernova Biotherapeutics Inc ÜBERRASCHT Anleger: Ist der Kurssprung um 33,2 % erst der Anfang? - Jetzt lesen! | ||
| CERENOME | 1,484 | -4,99 % | Cerenome, Inc.: Cerenome Expects $1.55 Million in CNSide Third Quarter Gross Billings | Lead test on track for 200 million covered lives and beneficiaries by early 2027 after CMS meeting On track to launch expanded CNSide testing menu with multiple tests in Q4 2026 HOUSTON, Sept. 30... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,960 | -6,67 % | Atossa plans shareholder stake in potential PRV proceeds | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 14,800 | +0,68 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,075 | -0,46 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| QUIDELORTHO | 9,624 | +0,65 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,525 | +0,60 % | Veru Inc.: Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines' RASONQUE) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial | ||
| LIFEWARD | 5,850 | -1,85 % | Lifeward Ltd. - 8-K, Current Report | ||
| CLOVER HEALTH INVESTMENTS | 3,720 | -4,62 % | Clover Health adds two directors to board | ||
| SENSEONICS | 8,800 | 0,00 % | TD Cowen bestätigt Kaufempfehlung für Senseonics Aktie aufgrund von Wachstumstreibern | ||
| TEMPEST THERAPEUTICS | 0,799 | -1,57 % | Tempest Therapeutics beruft Nancy Freda-Smith in den Verwaltungsrat | ||
| NANO-X IMAGING | 0,633 | -0,50 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| IMUNON | 1,120 | 0,00 % | Neues Krypto-Bänkli in Vaduz zittert: Bekannter Ex-Bär-Boss Paul Arni will mit Celsion durchstarten ... |
NEWGENIVF GROUP LIMITED gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,125 Euro und damit -3,10 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEWGENIVF GROUP LIMITED finden Sie auf Wallstreet Online.